All Marburg virus articles
-
NewsWhat factors influence likelihood and severity of Ebola outbreaks?
Two new papers looked at factors that contribute to how Ebola outbreaks begin and how severe they become. This Q&A looks at how the results could inform public health interventions to prevent pathogen emergence or slow the spread of Ebola and other infectious diseases.
-
NewsScientists reveal how deadly Marburg virus enters human cells, identify therapeutic vulnerability
Researchers found that the Marburg virus, one of the world’s deadliest pathogens, is unusually efficient at getting inside human cells. They also showed that the virus’s entry protein contains structural features that explain this efficiency and point to a strategy for blocking infection.
-
NewsSix years after COVID-19’s global alarm: Is the world better prepared for the next pandemic?
Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease. As we cross this six-year mark, WHO asks: Is the world better prepared for the next pandemic?
-
NewsResearchers discover how Ebola and Marburg disrupt the gastrointestinal tract
A new study sheds light on the mechanisms behind the damage caused by Ebola (EBOV) and Marburg virus (MARV) to the gastrointenstinal tract. TIt found that both viruses are capable of infecting and replicating within human gut epithelial cells and that the viruses interfere with the cells’ ability to regulate fluid secretion, mirroring the severe symptoms observed in patients.
-
NewsGlobal Virus Network issues warning on the Marburg virus outbreak in Ethiopia
The Global Virus Network (GVN) has issued a statement on the newly confirmed outbreak of Marburg virus disease (MVD) in southern Ethiopia. This represents the country’s first documented outbreak of Marburg virus and raises urgent public health, research, and surveillance imperatives.
-
NewsOrganoids reveal the secrets of bat immunity
Researchers successfully infected both bat organoids and human airway organoids with the Marburg virus. Compared to the human models, bat organoids exhibited a significantly higher baseline antiviral immune activity even before infection.
-
NewsTowards improved pandemic preparedness: Launch of new EU project COMBINE
A project for the targeted development of antiviral therapies for newly emerging viruses, COMBINE focuses on the critical virus-cell binding step, aiming to identify key factors and potential therapeutic targets involved early in viral infections.
-
NewsA Marburg virus outbreak was confirmed in Tanzania
WHO has announced that an outbreak of Marburg virus disease in Tanzania has been confirmed, with 25 suspected cases. Outbreak control measures have been established since the announcement.
-
NewsExperts develop laboratory toolkit for patients with viral hemorrhagic fevers such as Marburg virus disease
New resource provides guidance for healthcare facilities to perform basic laboratory testing in a safe and effective manner for patients at risk for Viral Hemorrhagic Fevers.
-
NewsNew risks raise pandemic threat on a global scale: GPMB warning
A plethora of risks increase the likelihood of new pandemics according to a new report from the Global Preparedness Monitoring Board (GPMB).
-
NewsMarburg virus disease reaches Rwanda for first time with 26 confirmed cases
On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedical Center and were positive for Marburg virus. ...
-
NewsDiscovery paves the way for antivirals against Ebola virus and its deadly relatives
The first detailed, complete images of the Ebola virus nucleocapsid may accelerate the development of antivirals to combat several filoviruses at once.
-
NewsVietnam hotspot IDed for viral disease emergence
Bat roosting sites, guano harvesting, and pig farms, all in close proximity, coupled with a high diversity of circulating coronaviruses indicates a high risk of CoV spillover, One Health surveillance reveals.
-
NewsMarburg vaccine shows promising results in first-in-human study
An experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial, according to a new paper.